Higher <i>RET</i> Gene Expression Levels Do Not Represent anAlternative <i>RET</i> Activation Mechanism in Medullary Thyroid Carcinoma
This study was designed to investigate whether <i>RET</i> (rearranged during transfection) mRNA over-expression could be considered an alternative driver event for the development of medullary thyroid carcinoma (MTC), and if different <i>RET</i> isoforms could play a role in...
Main Authors: | Chiara Mulè, Raffaele Ciampi, Teresa Ramone, Alessandro Prete, Antonio Matrone, Virginia Cappagli, Liborio Torregrossa, Fulvio Basolo, Rossella Elisei, Cristina Romei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/10/1542 |
Similar Items
-
RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells
by: Cristina Romei, et al.
Published: (2021-03-01) -
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib
by: Carla Gambale, et al.
Published: (2024-01-01) -
Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection
by: Qin Huang, et al.
Published: (2020-05-01) -
RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report
by: Vassos Neocleous, et al.
Published: (2023-06-01) -
Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea
by: Han-Sang Baek, et al.
Published: (2023-03-01)